Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells

We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus cytokine-induced killer cells.

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Zhenzhen eHui, Xinwei eZhang, Baozhu eRen, Runmei eLi, Xiubao eRen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-12-01
Subjects:	Cytokine-Induced Killer Cells Immunotherapy Thrombocytopenia Non-small cell lung cancer Pembrolizumab
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00633/full